Summary & Overview
CPT 90481: Multicomponent COVID-19 Vaccine Administration, Intramuscular
CPT code 90481 designates administration of an additional component of a multicomponent SARS–CoV–2 (COVID–19) vaccine by intramuscular injection. As an add‑on administration code, it captures incremental vaccine delivery effort when a multicomponent formulation requires separate administration steps. Nationally, accurate use of this code affects vaccine administration reporting, provider billing for incremental services, and public health vaccination tracking.
This analysis covers major national payers including Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. Readers will find a concise overview of code purpose and clinical context, typical sites of service, and what to expect in payer coverage and claims processing. The publication summarizes benchmark considerations, common billing scenarios for multicomponent COVID‑19 vaccines, and relevant policy updates affecting add‑on vaccine administration codes.
Intended for coding managers, revenue cycle staff, and health policy analysts, the report clarifies when CPT code 90481 is applicable, outlines common documentation needs, and highlights areas to verify with payers. Data not available in the input regarding modifiers, associated taxonomies, ICD‑10 diagnoses, related codes, and payer-specific reimbursement rates is noted where applicable.
Billing Code Overview
CPT code 90481 describes administration of a multicomponent SARS–CoV–2 (COVID–19) vaccine by intramuscular injection as an add-on code representing administration of an additional component. The code indicates the provider performed an intramuscular vaccine administration specifically for a multicomponent COVID‑19 vaccine when an extra component beyond the primary administration is given.
-
Service type: Vaccine administration (intramuscular)
-
Typical site of service: Ambulatory clinic, pharmacy immunization area, public health clinic, or other outpatient settings where intramuscular vaccinations are provided.
Clinical & Coding Specifications
Clinical Context
A middle-aged adult presents to a primary care clinic or mass vaccination site for a COVID-19 vaccine booster. The patient is screened by nursing staff for contraindications, allergies, and recent illnesses. After informed consent and documentation of prior vaccine history, the provider (physician, nurse practitioner, physician assistant, or licensed nurse) administers an intramuscular injection of a multicomponent SARS–CoV–2 vaccine. During administration of a multi-component vaccine series that requires an additional component at the same visit, the provider documents use of the add-on administration code 90481. Observation for immediate adverse reaction (typically 15–30 minutes) follows, and vaccination details are recorded in the immunization registry and the medical record, including vaccine manufacturer, lot number, route, site, and the reason for the additional component when applicable.
Coding Specifications
| Modifier | Description | When to Use |
|---|---|---|
59 | Distinct procedural service | Use when a separate and independent vaccine administration is performed at the same encounter and documentation supports distinct services. |
25 |